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Urinary incontinence (UI) is a serious health problem in 
women.1 The International Urogynecological Association 
and the International Continence Society define UI as the 
discomfort produced by any involuntary loss of urine 
through the urethra.2,3 This condition is often under 
diagnosed because of health professionals seldom ask 
women about UI, and In turn, women do not discuss the 
complaint because of embarrassment or the perception 
that UI is a normal symptom of aging.1 Data from the 
Study of Women’s Health Across the Nation (SWAN) 
suggests that belonging to an Afro-American ethnic 
group and the increase of age were conditions associated 
with a forty-eight and nine percent respectively, less 
probability of reporting UI.4  
The same authors pointed out that women with greater 
severity of UI had a high probability of reporting this 
condition if the symptoms were daily, weekly or monthly, 
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in comparison with those women who reported symptoms 
less than once a month.4 Urinary incontinence prevalence 
varies between 26-61%.1 Recent data suggest that among 
middle-aged women up to 45% experienced UI episodes 
a few times a month, while 15% referred this condition 
almost daily.4 Dieffeux reported that UI presence is 
higher in white women than in Afro-descendant or Asian 
women independently of other factors.5  
Aging, obesity, being overweight, pelvic floor 
dysfunction, diabetes, history of vaginal delivery, 
gynecological surgeries, urinary infections, smoking, 
sedentary lifestyle, depression, and use of neuroactive 
drugs have been related to the presence of UI.6,7 Several 
scales have been proposed to identify UI, the most 
frequently used are: International Consultation on 
Incontinence Questionnaire Short Form (ICIQ-SF), 
Incontinence Quality of Life Questionnaire (IQOL), 
Overactive Bladder Questionnaire (OAB-q), and 
Incontinence Impact Questionnaire (IIQ). Some of these 
have been validated in various languages.5,8-11 Data on UI 
in climacteric Afro-descendant women in Latin America 
is limited and the lack of prevalence records is 
noteworthy. The aim of this study was to determine the 
prevalence of UI and its related factors in climacteric 
Afro-descendant women from the Colombian Caribbean. 
METHODS 
A cross-sectional study was carried out as a part of the 
CAVIMEC (Calidad de Vida en la Menopausia y Etnias 
Colombianas) project, approved by the ethics committee 
at Universidad de Cartagena, Colombia. This 
investigation supports the Collaborative Group for 
Research of the Climacteric in Latin America 
(REDLINC) and the OMEGA-II Women’s Health 
Project.  
The inclusion criteria were to be healthy women aged 40-
59 that recognize themselves as Afro-descendant, with 
typical phenotypic characteristics and born and raised in 
settlements of descendants of enslaved Africans brought 
to the Americas in the colonial era with little ethnic 
mixing and low socioeconomic condition. Participants 
included women from municipalities of Santa Ana, Barú 
and Ararca, all part of the insular area of Cartagena in the 
Colombian Caribbean. The study was conducted in 2018. 
A group of trained female interviewers and health 
professionals belonging to the same communities 
recruited the participants in a door to door survey. They 
identified each woman and explained the scope of the 
research and the tools used. Exclusion criteria were 
women with physical or mental disorders who could not 
fill in the form, along with those who were illiterate, 
pregnant, being treated with chemotherapy or 
radiotherapy, and those who did not want to participate 
were excluded. Incorrectly filled in forms were not 
considered. A unique form was designed with different 
sections. In the first, participants were asked about socio-
demographic characteristics. The second section included 
the ICIQ-SF and the 10-item Cervantes Scale. The ICIQ-
SF was developed by Avery et al to assess the presence 
and severity of UI; this questionnaire consists of three 
items asking on the frequency and quantity of leaked 
urine and its impact on daily life over the last four weeks 
with Likert-type answers.8  
The total score is obtained by adding all answers, with a 
maximum score of 21. Klovning et al proposed that a 
score of 0 indicates absence of UI, and ≥ 1 its presence.12 
In addition, four categories of severity have been 
established: 1-5: mild, 6-12: moderate, 13-18: severe and 
19-21: very severe.8 A fourth item not applied to the 
women studied here explores eight activities that provoke 
involuntary leaks according to the women's perception 
but these are not quantified using the scale.  The 10 item 
cervantes scale is an adaptation of the 31-question 
version used to evaluate quality of life for menopausal 
women over the previous four weeks.13 The following 
items were taken from the abridged scale:  
• I am afraid of making physical effort because of 
possible urine loss 
• I feel vaginal itching due to excessive dryness. 
These two statements were assessed by the participants 
with Likert-type options. Finally, the women’s corporal 
weight was measured using a digital and calibrated 
weighing scale of Kenwell brand with a maximum 
capacity of 150kg. Height was measured using a 
stadiometer; waist circumference was measured at the 
level of the umbilicus, and the hip circumference at the 
level of the iliac crests with a flexible ruler while the 
woman was standing.  
Nutritional status was established based on the 
classification of the body mass index (BMI) suggested by 
the World Health Organization.14 According to the ATP-
III, abdominal obesity was established to be >88cm waist 
circumference1.15 Menopausal status was defined by 
application of the STRAW+10 staging system.16 The 
current intake of antidepressants, anxiolytics or 
antipsychotics was considered as use of psychoactive 
drugs (PD). 
The last Colombian population census, carried out in 
2005, established that 4,347,590 women were aged 40-
59; 382,588 (8.8%) belonged to black, mulato, Afro-
Colombian or racial ethnic groups, denominated Afro-
descendants in this study. Some 11.3% of that community 
lives in the Caribbean region, thus, 43,232 women were 
considered.  
A sample size of 371 women was calculated with a 
50% degree of heterogeneity, 5% error, and a confidence 
level of 95%, a supplementary 10% was considered to 
compensate the refusals and another additional 10% to 
compensate for incorrectly fulfilled forms. Therefore, the 
initial survey included 448 women.  
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Statistical analysis 
The EPI-INFO 7.2.2.6 statistical program (Centers for 
Disease Control and Prevention, Atlanta, USA, 2018) 
was used to analyze the data. The Kolmogorov-Smirnov 
test was used to assess the normality of the sample. The 
continuous data was presented in median with 
interquartile range; categorical data was expressed in 
absolute numbers and percentages with 95%CI. 
Differences between women with and without UI were 
assessed with ANOVA or Student’s t-test and Mann-
Whitney or Kruskal-Wallis tests.  
The Bartlett test was used to evaluate the homogeneity of 
measured variance. Categorical variables were evaluated 
with χ2 or Fisher tests. An unadjusted logistic regression 
(OR) and adjusted logistic regression (aOR) with 95%CI 
were carried out with UI as dependent variable; the socio-
demographic characteristics as well as the two questions 
of the 10-item Cervantes Scale were used as independent 
variables. A Spearman correlation coefficient (rho) was 
estimated between socio-demographic quantitative 
variables and punctuations of ICIQ-SF. A p value of 
<0.05 was considered to be statistically significant. 
Participants were voluntary and anonymous and gave 
their previous informed consent according to the 
Declaration of Helsinki. Biological samples were not 
taken. The scientific, technical and administrative rules 
for health research, established in the Resolution 008430 
of 1993 by the Ministry of Health and Social Protection 
of Colombia were adhered to, and the present study is 
free of risks. Participants could stop filling out the form 
when they wanted to. All the incomplete documents were 
destroyed.  
RESULTS 
Of the initial sample, 9 (2.0%) women refused to 
participate and 69 (15.4%) forms were incorrectly 
completed; therefore, 370 (82.6%) women were finally 
included in the study.  
The women's average age and BMI was 49.0 (10.0) years 
and 27.2 (8.5) kg/m respectively, 12.7% had arterial 
hypertension (AH); 6,2% had diabetes mellitus, 34.6% 
had previously undergone hysterectomy and 49.5% were 
in the postmenopausal stage; 14 (3.8%) women had UI 
according to the ICIQ-SF. Comparing women with and 
without UI, differences were observed only when 
subjects took in PD, had a current partner, history of 
pregnancy-induced hypertension (PIH) and current AH 
(Table 1). 
Among the 14 women with UI complaints, two of each 
three reported loss of urine around once a week or less. 
Half of them manifested to be afraid of making physical 
effort because of possible urine loss or feeling vaginal 
itching due to excessive dryness (Table 2). ICIQ-SF 
identified three grades of UI: mild: 50.0% (95% CI: 23.0-
76.9), moderate: 42.8% (95% CI: 17.6 - 71.1) and severe: 
7.1% (95% CI: 0.2-33.9). None of the women presented 
very severe UI. Cronbach's alpha was estimated to be 
0.791.   
A binary logistic regression model was used to establish 
factors associated with UI (Table 3). The used PD and 
history PIH were significantly associated with UI OR: 
15.09 (95% CI:1.62-140.27) and OR: 7.07 (95% CI: 
1.58-31.53) respectively. A significant statistical 
association was not observed between the number of 
daily cups of coffee and UI. There was no significant 
correlation among age, education, weight, height, BMI, 
and number of sexual encounters per week with UI,             
p >0.05. 
DISCUSSION 
In Latin America and the Caribbean, the Afro-descendant 
population is constituted of individuals from black ethnic 
groups. The term "African-American" usually tends to be 
assigned to the black population residing in North 
America. In 2015, it was indicated that 21% of the total 
population of Latin America was Afro-descendant, with 
Brazil and Cuba having the highest proportion among its 
population (35-55%), followed by Ecuador, Panama, 
Costa Rica and Colombia, which have 7-11% of Afro-
descendant communities, according to the Economic 
Commission for Latin America and the Caribbean 
(CEPAL).17  
Several countries have been passing laws to protect and 
respect the Afro-descendant population. The year 2011 
was declared “International Year for People of African 
descent” by the United Nations; also, the period 2015-
2024 was named the “International Decade for People of 
African Descent”.17 The CAVIMEC research project, that 
supports the present study, has reported several situations 
that affect the health and quality of life conditions of 
climacteric Afro-Colombian women.18-20  
The UI prevalence observed in non-hospitalized Afro-
descendant women in this study was close to 4%. This 
figure is much lower than the 24% reported by Rebassa et 
al among Spanish women using the same questionnaire.21  
In other studies, in Russia, the Czech Republic and 
Turkey, numbers were even higher: one in four women 
aged between 40-59 years, all of them contacted in their 
place of residence, manifested some type of UI and it was 
still higher in those who were over 60 years old.22  
In Norway, the researchers found that 27-30% of the               
50-59 age group reported an increase in UI over the 
previous few years.23 Finally, Cárdenas et al found that in 
USA the prevalence of UI was of 48% in postmenopausal 
women and 30% in premenopausal women.24 
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Age, years  49.0 (10.0) 48.5 (10.0) 49.0 (10.0) 0.86 
Education years 5.0 (6.0) 5.0 (4.0) 5.0 (6.0) 0.35 
Children 4.0 (2.0) 5.0 (4.0) 4.0 (2.0) 0.05 
Coitus per week 1.0 (3.5) 1.0 (3.0) 1.0 (3.5) 0.26 
Body Mass Index kg/m2 27.2 (8.5) 31.0 (12.4) 27.1 (8.4) 0.34 
Waist-hip ratio cm  0.91 (0.07) 0.88 (0.06) 0.91 (0.06) 0.52 
Waist circumference cm 92.0 (16.0) 90.0 (12.0) 92.0 (16.0) 0.20 
 n (%)  
Age range years 
40-49 204 (55.2) 7 (50.0) 197 (55.3) 
0.69 
50-59 166 (44.8) 7 (50.0) 159 (44.7) 
Level of education years 
Less than 11 353 (95.4) 12 (85.7) 341 (95.8) 
0.07 
High or equal to 11 17 (4.6) 2 (14.3) 15 (4.2) 
Rank of children 
0 2 (0.5) 0 2 (0.5) 
0.24 
1 and 2 81 (21.9) 2 (14.3) 79 (22.2) 
3 and 4 168 (45.4) 4 (28.6) 164 (46.1) 
5 and more 119 (32.2) 8 (57.1) 111 (31.2) 
Marital status 
Married 83 (22.4) 1 (7.1) 82 (23.0) 
0.06 
Civil union 218 (58.9) 7 (50.00) 211 (59.3) 
Divorced 37 (10.0) 2 (14.3) 35 (9.8) 
Single 15 (4.0) 2 (14.3) 13 (3.7) 
Widowed 17 (4.6) 2 (14.3) 15 (4.2) 
Current partner  Yes 298 (89.5) 8 (57.1) 290 (81.5) 0.02 
Nutritional status 
 
Underweight 15 (4.0) 1 (7.1) 14 (3.9) 
0.13 
Normal weight 108 (29.2) 4 (28.7) 104 (29.2) 
Overweight 121 (32.7) 1 (7.1) 120 (33.7) 
Obesity 126 (34.1) 8 (57.1) 118 (33.2) 
Abdominal obesity  Yes 249 (67.3) 8 (57.1) 241 (67.7) 0.40 
Sedentary behavior Yes 13 (3.5) 1 (7.1) 12 (3.3) 0.45 
Use of oral contraceptives Yes 19 (5.1) 1 (7.1) 18 (5.1) 0.72 
Estrogen replacement therapy Yes 72 (19.5) 0 72 (20.3) 0.06 
Use of psychotropic drugs Yes 13 (3.5) 3 (21.4) 10 (2.8) 0.00 
Use of phytoestrogens  Yes 40 (10.8) 0 40 (11.24) 0.18 
Current smoking Yes 48 (13.0) 2 (14.3) 46 (13.0) 0.88 
Alcohol consumption Yes 43 (11.6) 3 (21.4) 40 (11.9) 0.24 
Coffee consumption  Yes 252 (68.2) 7 (50.0) 245 (68.8) 0.13 
Church attendance  Yes 275 (74.3) 10 (71.4) 265 (74.4) 0.80 
Arterial hypertension  Yes 47 (12.7) 7 (50.0) 40 (11.3) 0.00 
Arterial hypertension in 
pregnancy 
Yes 99 (26.7) 8 (57.2) 91 (25.6) 0.00 
Diabetes mellitus  Yes 23 (6.2) 2 (14.3) 21 (5.9) 0.20 
Bilateral oophorectomy Yes 46 (12.4) 1 (7.1) 45 (12.6) 0.54 










Previously hysterectomized Yes 128 (34.6) 4 (28.6) 124 (34.8) 0.62 
Uterine resection before 
menstruation 
Yes 49 (13.3) 1 (7.1) 48 (13.5) 0.49 
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Table 2: Perception of genitourinary symptoms in women with urinary incontinence. 
International consultation on incontinence questionnaire-short form  
ICIQ-SF 
n (%) (95%CI) 
How often do you leak urine? 
Never 1 (7.1) (0.18-33.87) 
About once a week or less often 9 (64.3) (35.14-87.24) 
Two or three times a week  1 (7.1) (0.18-33.87) 
About once a day 1 (7.1) (0.18-33.87) 
Several times a day  2 (14.3) (1.78-42.81) 
All the time 1 (7.1) (0.18-33.87) 
How much urine do you usually leak? 
None 3 (21.5) (4.66-50.84) 
A small amount  9 (64.3) (35.14-87.24) 
A moderate amount  1 (7.1) (0.18-33.87) 
A large amount 1 (7.1) (0.18-33.87) 
How much does leaking urine interfere with your 
everyday life? 
0 (Not at all) 4 (28.6) (8.39-58.10) 
1-2 5 (35.7) (12.76-64.86) 
3 2 (14.3) (1.78-42.81) 
4 2 (14.3) (1.78-42.81) 
5-6-7-8-9 1 (7.1) (0.18-33.87) 
10 (A great deal) 0 
Cervantes short form scale -10 n (%) (95% CI) 
I am afraid of performing physical efforts because 
my urine leaks  
Never 7 (50.0) (24.04-76.96) 
Seldom 7 (50.0) (24.04-76.96) 
Sometimes 0 
Almost always 0 
All the time 0 
I have vaginal discomfort and dryness  
Never 7 (50.0) (24.04-76.96) 
Seldom 6 (42.9) (17.66-71.14) 
Sometimes 0 
Almost always 1 (7.1) (0.18-33.87) 
All the time 0 
 
Table 3: Factors associated with urinary incontinence. 
Variable OR (95% CI) P aOR (95% CI) P 
Use of psychotropic drugs 9.43 (2.27-39.15) 0.009 15.09 (1.62-140.27) 0.01 
Current partner 0.30 (0.10-0.90) 0.03 0.35 (0.08-1.46) 0.15 
Arterial hypertension 7.90 (2.63-23.68) <0.001 3.64 (0.86-15.35) 0.07 
History of arterial hypertension in pregnancy 3.88 (1.31-11.49) 0.01 7.07 (1.58-31.53) 0.01 
Current smoking 1.12 (0.24-5.18) 0.70 1.19 (0.17-8.02) 0.85 
Alcohol consumption  2.15 (0.57-8.05) 0.21 1.11 (0.15-7.91) 0.91 
Coffee consumption 0.45 (0.15-1.32) 0.15 0.67 (0.17-2.58) 0.56 
Use of oral contraceptives 1.44 (0.17-11.66) 0.52 1.55 (0.11-20.69) 0.73 
Sedentary behavior 2.20 (0.26-18.25) 0.39 7.26 (0.59-88.30) 0.11 
Church attendance  0.85 (0.26-2.80) 0.76 1.12 (0.22-5.58) 0.88 
Diabetes mellitus 2.65 (0.55-12.65) 0.21 1.68 (0.26-10.57) 0.57 
Abdominal obesity 0.63 (0.21-1.87) 0.39 0.77 (0.19-3.09) 0.72 
Previously hysterectomized 0.74 (0.23-2.43) 0.77 0.21 (0.04-1.10) 0.06 
Bilateral oophorectomy 0.53 (0.06-4.16) 1.00 0.58 (0.05-6.61) 0.66 
I am afraid of performing physical efforts 
because my urine leaks 
0.69 (0.23-2.03) 0.59 0.27 (0.02-2.86) 0.28 
I have vaginal discomfort and dryness  2.78 (0.95-8.15) 0.06 7.07 (0.73-67.82) 0.08 
 
Data on UI in women and race are contradictory. Leroy et 
al in a systematic review of the literature suggested that 
the presence of UI was higher in white and Hispanic (17-
41%) than it is in black and Asian (9-26%) women.25 
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They also found differences in the type of UI, which 
could be explained by the exposure to factors such as 
urethral closure pressure, urinary tract infections, being 
overweight, obesity, constipation, diabetes mellitus type 
2, chronic obstructive pulmonary disease, and symptoms 
of depression. Studies on UI involving Latin American 
indigenous women and those involving Afro-descendant 
women are scant. Monterrosa et al identified a high 
prevalence of urogenital disorders including vaginal 
dryness and bladder and sexual function disturbances in 
Colombian indigenous postmenopausal women.26 Severe 
UI was detected in one of each two women of this 
population. Furthermore, Arteta et al found a high 
prevalence of severe bladder dysfunctions among 
indigenous women aged 40-59 from the Colombian 
Caribbean.27 
In the present study, 57.1% of the participants with UI 
were postmenopausal. Six out of ten women were 
overweight/obese or with abdominal obesity and half of 
them had a sexual partner. This figure is two folds those 
observed by Juliato et al who reported a 23.6% of UI 
among Brazilian women aged 52.5±4.4.28 Two thirds of 
these women were in postmenopause, one third was 
overweight, half were obese, 80.2% had abdominal 
obesity, and 77.4% had a sexual partner. In this regard, 
Çayan et al in a study involving 1217 sexually active 
women from Turkey showed a UI prevalence of 14.6%. 
In this study, UI complaints were more common among 
women of advanced age, high BMI, low educational 
level, and older sexual partners.10 
Cagnacci et al showed that 35.6% of postmenopausal 
Italian women reported UI.6 In Spain, 25.2% of women 
expressed moderate/severe UI, 34.8% experienced loss of 
urine once a week and 75.6% reported minimal escapes 
of urine.21 In contrast, in present sample, half of the 
women with UI expressed it as moderate to severe; two 
out three women reported loss of urine once a week and a 
similar amount presented a minimal loss of urine. In 
another study, involving mestizo population, from a 
geographic area of ancestral indigenous American 
settlement, it was found severe/very severe UI in 28.4% 
of women and vaginal dryness in the 64.4%.29 Studies 
that explain the association between severity of UI and 
ethnic group were not found. 
It should be noted that it is difficult to identify the factors 
related to UI. Biopsychosocial determinants and medical 
and surgical history have been assessed by different 
authors.5,7,28 In the present study, the used of PD OR: 
9.43 (95% CI: 2.27-39.15), history of PIH OR: 3.88 (95% 
CI: 1.31-11.49) and having AH OR: 7.90 (95 CI%: 2.63-
23.68) were associated with a greater presence of UI, 
whereas having sexual partner was a protective factor 
OR: 0.30 (95 CI%: 0.10-0.90). This applies only when 
the estimations were not adjusted or when the 
adjustments were carried out with the different 
considered variables. Only the used of PD and history of 
PIH continued to be factors associated with UI. 
Townsend et al found UI prevalence of 14% using a 
different questionnaire from the ICIQ-SF in Mexican 
postmenopausal women, 60% of them aged 50-59, older 
than those observed in the study, which included women 
in all menopausal stages.30 In addition, the researchers 
found the following factors to be associated with UI: 
having four or more children aOR: 1.43                                
(95% CI: 1.04-1.96), using hormonal therapy aOR :1.26 
(95% CI: 1.14-1.39), and being a current smoker aOR : 
1.23 (95% CI: 1.09-1.39). However, statistically 
significant correlations for nutritional status, diabetes or 
arterial hypertension were not found. On the other hand, 
Cagnacci et al showed that 35.6% of postmenopausal 
women, with an average age of 55.8±5.8 years, reported 
UI by means of tools different from ICIQ-SF in an Italian 
university hospital.6 Then, when a logistic regression 
model was applied, the only associated factor was 
bladder prolapse OR: 3.72 (95% CI: 2.59-5.34), p=0.001. 
Urinary incontinence is a component of geriatric 
syndrome, which is defined as a multifactorial health 
status that increases as multisystemic disorders are 
accumulated, making people more vulnerable in the face 
of challenging situations with the consequent 
deterioration of quality of life and disability.31 This 
condition must be considered in a comprehensive way 
since it is a syndrome with a high burden of disease for 
the patients and their families.   
Ranges of prevalence of UI are broad with important 
differences among the studies without noteworthy 
biological explanations.1 However, several reasons must 
be considered. First, a diversity of tools and resources 
were applied to obtain information. Second, the decisions 
made to interpret UI as a symptom or disease by women 
and health professionals are highly subjective.1,3,25 The 
diversity of prevalence makes it necessary to study the 
data of each community in order to establish early actions 
for primary care that involve efficient treatment and 
avoidance of the deterioration of women's quality of life.  
Health professionals should ask about UI to climacteric 
women. The menopausal transition implies anatomical 
and physiological changes due to estrogen deficiency and 
aging. It has been pointed out that the reduction of elastin 
and blood flow, proliferation of connective tissue, vaginal 
epithelium slimming, changes in the vaginal maturation 
index, glycogen decrease in vaginal epithelial cells, 
changes in the facultative vaginal flora, and vaginal pH 
increase are normal symptoms in this stage. Due to the 
aforementioned symptoms, women usually present 
urogenital and vulvovaginal signs that, nowadays, are 
grouped under the term genitourinary syndrome of 
menopause.32,33 
In spite of the low prevalence detected in this study the 
need to look for early manifestations is mandatory. 
Clinical records should include the amount and frequency 
of spontaneous urine leaked, nocturia, urge, and the 
impact of this complaints since all of them have a 
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negative impact on quality of life and could involve the 
deterioration of state of mind, depression, anxiety, low 
self-esteem, embarrassment, and social isolation.1,10,23,30  
This study is mainly limited by its cross-sectional design 
and by the lack of more objective measures such as 
urodynamics, Q-tip test or ultrasounds. The survey did 
not ask the participants if they had been previously 
diagnosed with UI, had felt embarrassment because of 
these manifestations, or if they had presented alterations 
of the pelvic floor. Other limitations include the lack of 
data on obstetric history, gynecological vaginal surgeries, 
urinary infections and types of UI.  
On the other hand, this study is one of the first carried out 
in a healthy Afro-descendant population in Latin 
America, in which the participants were interviewed 
outside health centers as an initial approach to UI in the 
region. However, the results could not necessarily be 
extrapolated to other communities. Finally, more studies 
involving other Afro-descendant populations are needed 
in order to establish a real estimation of the statistical 
weight of the associated factors. Sufficient comparative 
studies that examine ethnic group do not exist to identify 
the race value as a variable in UI prevalence. The 
application of different tools to explore UI is limited to 
comparisons among the obtained information. Although 
it is true that UI is considered to be a geriatric syndrome, 
this disorder is present in middle-aged women, and so the 
topic requires more basic and clinical studies to develop 
prevention and intervention actions. In conclusion: 
almost 4% of climacteric Afro-descendant women in the 
Colombian Caribbean, assessed presented UI. The main 
related factors were the use of psychotropic drugs and a 
history of pregnancy-induced hypertension. 
CONCLUSION 
The prevalence of UI among climacteric afro-descendant 
women was close to 4%. A history of PIH and PD 
consumption were related factors. 
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